New Age Alpha Advisors LLC Buys Shares of 23,431 HCA Healthcare, Inc. (NYSE:HCA)

New Age Alpha Advisors LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 23,431 shares of the company's stock, valued at approximately $7,033,000.

A number of other institutional investors also recently modified their holdings of the company. Congress Wealth Management LLC DE boosted its holdings in shares of HCA Healthcare by 3.4% in the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after buying an additional 34 shares during the last quarter. Evergreen Private Wealth LLC grew its stake in HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after buying an additional 35 shares during the last quarter. Mediolanum International Funds Ltd boosted its holdings in shares of HCA Healthcare by 0.3% during the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock worth $3,153,000 after acquiring an additional 36 shares during the period. Prairie Wealth Advisors Inc. increased its stake in shares of HCA Healthcare by 6.1% during the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock worth $210,000 after purchasing an additional 40 shares during the period. Finally, Whittier Trust Co. grew its holdings in HCA Healthcare by 3.6% in the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after buying an additional 41 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Remove Ads

Analysts Set New Price Targets

A number of research firms have commented on HCA. Barclays lowered their price objective on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. Truist Financial lowered their target price on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Royal Bank of Canada decreased their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a research note on Monday, January 27th. Finally, JPMorgan Chase & Co. restated a "neutral" rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $385.67.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Trading Up 0.1 %

HCA traded up $0.34 during trading on Tuesday, hitting $345.89. The company's stock had a trading volume of 301,466 shares, compared to its average volume of 1,342,756. The stock's fifty day moving average price is $325.24 and its 200-day moving average price is $340.60. The firm has a market capitalization of $85.16 billion, a P/E ratio of 15.79, a PEG ratio of 1.10 and a beta of 1.68. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the company earned $5.90 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were issued a dividend of $0.72 per share. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.83%. HCA Healthcare's dividend payout ratio is presently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.